Dr. Ajit Dangi

President and CEO, Danssen Consulting

Dr. Ajit Dangi is President and CEO of Danssen Consulting, a consultancy firm specialising in Pharmaceuticals, Life Sciences and Healthcare. He is also Chairman of the Board of Fulford India Ltd. a subsidiary of Merck & Co. Inc.USA, and is also on the board of Atul Bioscience Ltd. Dr. Dangi has served as Director General of Organisation of Pharmaceutical Producers of India ( OPPI ), a premier association of Research based International Pharmaceutical Companies for over seven years, where he played a key role in bringing IPR regime in India . He is former President & Executive Director of Johnson & Johnson Ltd., India where he served for 20 years in various capacities. Dr. Dangi also worked with Unilever Group Co. in U.K. for five years before returning to India. He is a Chemistry graduate from University of Bombay and later earned his Masters and Doctorate Degrees( Ph. D.) in Pharmaceutical Chemistry from University of London , England. He has also undergone an Advanced Management Programme from Kellogg Graduate School of Business, Chicago, U.S.A. and coaching from world renowned CEO Coach Marshal Goldsmith.

Dr. Dangi has over three an half decades of rich and varied experience in Research, Manufacturing, Project Management, Sales & Marketing and General Management in the Pharmaceutical and Healthcare Industry in India and abroad. He has also served on various Industry bodies such as President of Pharmaceutical & Allied Manufacturers & Distributors Association Ltd. ( PAMDAL ) , Vice President of OPPI and Chairman of its HRD Committee. He has served on the Advisory Board of United States Pharmacopeia . In 2011, he was awarded ` Pharma Professional of the Decade Award ` instituted by Indo American Chamber of Commerce and Pharma Leadership Magazine. He is a life member of Indian Pharmaceutical Association and serves on its Central Executive Council and has served as member of the Indian Pharmacopeia Committee. Widely travelled in North America, Europe and Asia Pacific, he takes keen interest in academic affairs and has served as Member of the Governing Body of Bombay College of Pharmacy and is a visiting faculty at various Management Institutes and Pharmacy Colleges in India. He has been Examiner for Ph.D. Studies at the University of Bombay and is a sought after Speaker / Panelist on many pharmaceutical conferences in India and abroad. He has authored several articles and papers in Scientific Journals and Magazines. He had been an active Rotarian and is a Paul Harris Fellow.

Bhalchandra G. Barve

Joint Managing Director Blue Cross Laboratories Ltd.

Bhalchandra G. Barve (33 years of Professional experience) is presently the Joint Managing Director of Blue Cross Laboratories Ltd. & Worked with Parke Davis (India) Limited.

Organizations Associated with.

  • Member of Rotary Club of Mumbai Parleshwar Senior Rotarian and Trustee of Rotary Club of Mumbai Parleshwar
  • Member of IDMA, Premium Association of Indian Drug Manufacturers in India
  • Chairman of IDMA Taxation Committee
  • Member of Bombay Chamber of Commerce and Industry.
  • Member of Indian Chambers of Commerce.
  • Member of Confederation of Indian Industry.


Lion Daara B. Patel

Secretary-General Indian Drug Manufacturers Association

Lion Daara B Patel is a Bachelor of Commerce from University of Mumbai and has a Diploma in Materials Management from Indian Institute of Materials Management (IIMM).

He has worked with multinational companies as well as large business houses like

  • Parke Davis (India) Limited as Director – Purchasing
  • Sinar Mas Group (Indonesia, Jakarta) as General Manager Procurement (Agribusiness Division)
  • Jet Airways (India) Limited as General Manager – Purchase, Properties & Administration


Currently (since 2002) he is the Secretary General of Indian Drug Manufacturers’ Association, an apex body of 1000 plus pharmaceutical and bulk drug manufacturers.

  • He is responsible for the smooth functioning of the association as per the constitution and By-Laws. He provides prompt response to members’ queries and problems, organizes industry specific seminars, training programs & workshops, makes presentations, chairs technical sessions at various industry events, efficient handling of pricing related issues, EXIM policy and regulatory & technical affairs, Industry Trade related issues. He also coordinates activities / issues with other Associations.
  • He has excellent leadership qualities and is an able administrator. He is responsible for the smooth functioning of the Association which includes P.R. activities, organizing and conducting Training Programmes and liaising with the Government and Ministry. He leads the association’s CSR initiatives.
  • He has successfully led delegations of Indian Pharmaceutical Companies jointly with FICCI and Reed Exhibitions to China as well as Japan for interactive meetings with SFDA, Ministry of Commerce, Chinese Pharmaceutical & API Manufacturers & CPIA.
  • He was invited by United States Pharmacopoeia as an Official Observer in Washington in April 2010 and as a Delegate in April 2015.
  • Bestowed with one of the most prestigious awards – "Pharma Professional of the Decade" by the Pharma Leaders Group in December 2014.
  • Recently Awarded by The Economic Times for 'Commendable contribution to the Pharmaceutical Industry'.
  • His other interest lies in various social associations; he is a very active member of Lions Clubs International and was the District Governor of Lions Clubs International, District 323 A1, Mumbai in 2008-2009.


Deepnath Roy Chowdhury

Managing Director of Strassenburg Pharmaceuticals Ltd.

Managing Director of Strassenburg Pharmaceuticals Ltd., a WHO GMP certified formulation manufacturer engaged in ethical marketing in the Indian Pharmaceutical Market. Strassenburg was awarded the ‘Economic Times Bengal Corporate Awards – 2015’ for Best Financial Performance.

Promoter Director of Cans & Closures Pvt. Ltd. – a leading manufacturer of PET packaging products catering to the Coca Cola chain and the Pharma Industry.

Was instrumental in launching the largest Stem Cell Banking network in the APAC region -- Cordlife, in India in collaboration with Strassenburg.

Has been an active member of the Indian Drug Manufacturers’ Association (IDMA) for the last several years and has served the Association in various capacities including Vice-President, East.

Is currently the National President of IDMA.

Kewal Handa

Managing Director of Pfizer Limited

Managing Director of Pfizer Limited, India from 2005 to 2012. Prior to this, has served as Executive Director - Finance, Pfizer Limited. Also Managing Director of Wyeth Ltd from 2009 to 2012.

Under his leadership, Pfizer India became one of the top ten pharmaceutical companies in India, due to new initiatives and innovative strategies implemented during his term. He constantly challenged the rules of the game – whether it was making Pfizer India the first MNC to enter into the branded generics space in India or explore a unique partnership with the Government to increase access.

Building a diverse organization is one of his key focuses. As part of this, he has driven the various teams to hire and retain women colleagues in management and most importantly in sales positions – an initiative unheard of in the Indian pharmaceutical industry. He has managed this by sensitization and developing policies that are women friendly. These initiatives are now case studies and were showcased at a ministerial roundtable held in Turkey.

Has diverse experience in Finance, Commercial, Strategy, Business Development, Merger & Acquisition, Banking, Corporate Affairs and he has also experience in sectors like Engineering, Consumer and Project Finance in companies like Schrader Scovill, Hindustan Liver Limited (HLL), Vidyut Blades & State Industrial Investment Corporation of Maharashtra (SICOM),

Has worked in the Domestic & Global Generic Businesses. Has wide experience in markets like US, South East Asia, Africa, Bangladesh, and Sri Lanka. Currently I also Mentor, start ups and work in Social Sector

He is qualified Management Accountant and Company Secretary and has a Masters Degree in Commerce. Has completed the Pfizer Leadership Development Program from Harvard University and the Senior Management Development Program from IIM, Ahmadabad. Has also done a Certificate course on Marketing Strategy from Columbia Business School, New York.

He was awarded the ‘India CFO 2004 – Excellence in Finance in an MNC’ by International Market – Assessment Group, the Bharat Shiromani Award in 2007 and the Pharma Leaders - Pharma Professional of the year 2010.

Satish Waman Wagh

Chairman & Managing Director of Supriya Lifescience Ltd.

Shri Satish Waman Wagh comes from a typical middle class working family. Initially he did his graduation in Economics, he again registered himself for a degree in science and passed his degree in Chemistry from University of Bombay. He started working as a Plant Supervisor in a Bulk Drug manufacturing company. After working for about 10 years in that capacity and gaining valuable experience and feel of a manufacturing industry, probably with his basic background of economics, the idea of starting his own unit started taking shape in his mind. In 1987 he took a bold decision to quit the job and jumped into the vast world of chemical manufacturing business on his own. With extremely meager financial support out of his own savings, due to the enthusiasm and dynamic ideas he could successfully convince the authorities and could garner financial support from MSFC. The formalities of purchasing a piece of land in remote place like Lote Parshuram Industrial Area of MIDC ware completed and small shed was erected out of available funds. The necessary machinery and equipments were brought and Mr. Satish W. Wagh started manufacturing Textile Auxiliaries and was successful in developing a market for his products despite the tough competition from large business houses in that field. However, as the things changed a need to diversify the activities were felt.

The opportunity was located and now it was a question of grabbing it on a right time. Once again the drive from within could not keep Mr. Satish Wagh passive and he took a bold step ahead and entered the field of manufacture of bulk drugs in 1993 starting his activities with Chlorpheniramine Maleate with initial manufacturing reactor of a capacity of 350 ltrs only. In last 25 years, Mr. Satish Wagh, has placed Supriya Lifescience Ltd. In the map of International Pharmaceutical world with flag of a major player in Anti-Histamine therapeutic segment. Today the Supriya Lifescience Ltd. is the largest manufacturer of Chlorphenirame Maleate in the world and exporting to more than 85 countries. Besides, mapping his own growth and continuous service to pharma & Chemicals Industry, Mr. Satish Wagh enthused and helped many young enthusiastic new entrepreneurs to mark their presence in pharma world.

Along with this contribution to Pharma Industry Mr. Satish W. Wagh is also a major player in manufacturing of various chemicals which is required for industries like Pharma, Textiles, Dyes, etc. Today, Mr. Satish W. Wagh is the VICE CHAIRMAN OF CHEMEXCIL. Mr. Satish Wagh is leading this council for more than 13 years & take care of 47 Billion Dollar of India’s chemical exports. Chemexcil have 6400 Manufacturers from all over India. In last two decades of manufacturing and exporting business, the company has achieved more than 25 awards for its’ outstanding achievements in various operation of business. Such as Best Quality Award, Best R & D, Consistent Export growth and Consistent Performance etc. from various government and non-government organizations, including prestigious Awards as mentioned below.

  • National Award for Best R & D – 2010 presented by Hon’ble Pratibha Patil
  • National Award for Best Entrepreneur -2007’ presented by Hon’ble Dr.Manmohan Singh.
  • National Award for Quality-2003’ presented by Hon’ble Dr.Abdul Kalam,
  • National Award for Best R & D-1999’ presented by Hon’ble Lalkrushna Advani achievements in small scale sector etc.
  • State Award in the Year 2008-2009 for Best Performance of Export presented by Hon.Rajendra Darda, Minister, Industries, Employment & Self Employment, Govt. of Mararashtra
  • State Award in the Year 2007-2008 for Best Performance of Export presented by Hon.Rajendra Darda, Minister, Industries, Employment & Self Employment, Govt. of Mararashtra.
  • Regional Award for the year 2000-2001 followed by State Award for Best Performance presented by Hon’ble Dr.Patangrao Kadam,
  • District Award for the year 1999-2000 followed by State Award for Best Performance presented by Hon’ble District Collector Shri.Mahesh Pathak


Sunil Bambarkar

Managing Director, Gattefosse India Pvt Ltd

M.Sc. Ph.D. Organic Chemistry from University of Mumbai and Marketing professional in International business having 25 years of experience in Pharmaceutical , personal care, OTC,API and flavours., in large Indian and multinational corporations. Having research publications and patent to credit.

Currently – Managing Director of Gattefosse India Pvt Ltd, a wholly owned Affiliate of Gattefosse Holding in France.

  • President of Indian Society of Cosmetic chemists (ISCC).
  • Member Central Executive Council (CEC) of the Indian Pharmaceutical Association (IPA).
  • Life member American Chemical Society.


Successful executive in the Pharmaceutical, Personal Care and Allied Industries.

S. M. Mudda

Director – Global Strategy

S.M.Mudda is a Pharmacy graduate with a Postgraduate Diploma in Management Studies. He has more than 39 years of wide experience in pharmaceutical industry covering all aspects of pharmaceutical manufacturing.

Currently, he is Director – Global Strategy (Technical) at Micro Labs Limited, Bangalore, a 2000 crore company, with whom he is associated for more than 30 years. He is responsible for all strategic decisions of the company.


  • An ability to provide technical and administrative leadership support, needed to raise the standards of operations of a company from local to the current international standards.
  • Well-connected with the global thought leaders in the areas of Pharmaceutical Quality Management and CGMP Regulation
  • Committed to adopt a Quality System Based-approach based on science and modern technology applicable to the industry.
  • Design & implementation of Quality Management System consistent with the current global regulatory requirements.

He has designed world-class, GMP-compliant facilities of various dosage forms such as, Oral Solid Dosage Forms- General Plants and dedicated plants for handling Penicilllins and Cephalosporins and facilities for Sterile Products such as Ophthalmic products in Blow-Fill-Seal Packs, Sterile powder for injections etc; at Micro Labs Limited, Bangalore and FDC Limited, Mumbai.

These plants have gone through several regulatory inspections and have been approved by the agencies such as UK MHRA, US FDA, WHO, MCC, SOUTH AFRICA, HEALTH CANADA and ANVISA BRAZIL.

  • Member of the Scientific Body of Indian Pharmacopoeia Commission, nominated by Ministry of Health, Government of India
  • Chairman of Regulatory Affairs Committee, Indian Drug Manufacturers’ Associaton (IDMA)
  • Chairman, IDMA Karnataka State Board
  • Member Committee of Administration – Pharmexcil, India
  • Chairman of Bangalore Chapter, ISPE (International Society of Pharmaceutical Engineers), India.
  • Director of ISPE (International Society of Pharmaceutical Engineers), USA, India Affiliate.
  • Life Member of Indian Pharmaceutical Association (IPA).

He has delivered lectures and has participated in panel disuccsions on several topics related to Pharmaceutical Industry in national and international seminars at prestigious forums.

He has co-authored a book “LABEL DESIGN AND LABELLING OF DRUGS” along with Mr. R .S. Iyer (A renowned Quality Guru).